Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge.

van den Doel, Petra

Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge. [electronic resource] - PLoS neglected tropical diseases Sep 2014 - e3101 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1935-2735

10.1371/journal.pntd.0003101 doi


Alphavirus Infections--immunology
Animals
Antibodies, Neutralizing--immunology
Antibodies, Viral--immunology
Chikungunya Fever--prevention & control
Chikungunya virus
Glycoproteins--immunology
Mice
Vaccines, Synthetic--immunology
Vaccinia virus--genetics
Viral Envelope Proteins--immunology
Viral Vaccines--immunology